Reported 6 months ago
Insiders are showing strong confidence in Shift4 Payments and Allogene Therapeutics by pouring millions of dollars into their stocks, signaling potential upcoming gains. Shift4 Payments specializes in payment solutions for online commerce and has seen recent insider buying activity from the CEO. On the other hand, Allogene Therapeutics is making strides in the biotech industry with a focus on CAR T therapies, and a board member recently purchased shares worth $5 million. Both companies have a 'Strong Buy' consensus rating and significant upside potential according to analysts.
Source: YAHOO